Private Equity Has Bought Into Florida Medicine. Here Is What Physicians Should Do About It.

A private equity firm now owns an Ohio hospital system. Humana is in talks to buy a Sarasota primary care network out of a private equity portfolio. Eight Brevard County primary care offices treating 37,000 Floridians changed hands in a single transaction earlier this year. Twenty-one Florida ENT practices operate under a single PE-backed roll-up. Ninety percent or more of the physician practice deals closing in 2026 have a private equity firm somewhere on the buy side.

If you have been waiting for the moment when private equity went from a niche concern of policy journals to the dominant force shaping how medicine is delivered in our state, that moment was last quarter. The reporting on this transition is now coming from every direction at once, and the picture the reports paint is not flattering, not uniform, and not optional reading for a Florida physician planning the next five years of their career.

What follows is a careful look at the data on private equity in healthcare, the contrasting cases for and against the trend, the specific Florida transactions that are reshaping local practice, and a place physicians can go for help navigating it.

The transactions reshaping Florida medicine

Three Florida deals from the past several months tell the story in compressed form.

Millennium Physician Group, a part of the Mosaic Health platform, acquired eight primary care locations in Brevard County earlier this year, picking up a team of physicians, advanced practice providers, and clinical staff serving approximately 37,000 active patients. Mosaic Health is backed by Triton Pacific Capital Partners and a syndicate of healthcare-focused private equity investors, and Millennium has now grown into one of the largest privately held primary care groups in the country.

In Sarasota, Humana is in active negotiations to acquire MaxHealth, a primary care network owned by Best Value Healthcare, the platform Arsenal Capital Partners built starting in 2019. The MaxHealth transaction would mark a payer absorbing a PE-backed Florida primary care footprint, a pattern that mirrors what Optum and UnitedHealth Group have been doing nationally for several years.

Elevate ENT, a PE-backed otolaryngology platform, now lists 214 providers across 104 locations in Texas, Louisiana, and Florida, operating under fourteen local brands. In Florida that includes the North Florida Center for Otolaryngology, Coastal Ear Nose & Throat, Orlando Ear Nose & Throat, Vero ENT, and South Florida ENT Associates. A patient in Vero Beach, Jacksonville, and Orlando who thinks they are seeing five different ENT groups is, under the holding company, seeing one.

These are not isolated transactions. According to the Private Equity Stakeholder Project’s tracking, private equity firms now drive more than 90 percent of physician practice M&A activity nationally, and Florida sits inside the top three states by deal volume in dermatology, gastroenterology, ophthalmology, orthopedics, and emergency medicine. The independent solo or small-group practice that defined Florida medicine through the 2000s is being rolled up at a pace the profession has not previously seen.

What the evidence says about patient outcomes

The independent research record on private equity in hospitals is now substantial enough that it can no longer be waved away as anecdote. The most-cited finding comes from the 2023 JAMA study by Sneha Kannan and colleagues, which analyzed Medicare beneficiaries treated at 51 hospitals acquired by private equity firms between 2009 and 2019 and matched them against 259 control hospitals. After acquisition, hospital-acquired adverse events rose by 25.4 percent. Patient falls increased 27.3 percent. Central line-associated bloodstream infections rose 37.7 percent. Surgical site infections doubled, even as surgical volume declined.

A subsequent analysis published in 2024 found that emergency department mortality rose by more than 13 percent at PE-acquired hospitals, with the increase tracking staffing and salary cuts in the emergency department and intensive care unit. Full-time staffing fell by nearly 12 percent in the studied facilities, and salary expenditures in the ED and ICU dropped 18 percent and 16 percent respectively.

A 2025 JAMA paper on patient experience after PE acquisition reported that the share of patients rating their hospital a nine or ten on the HCAHPS survey fell at acquired facilities compared with controls, with the drop persisting across the postacquisition period studied.

The catalog of high-profile PE-related hospital closures has its own weight. Crozer-Chester Medical Center in Delaware County, Pennsylvania, closed soon after acquisition by Prospect Medical Holdings, displacing 3,000 employees and roughly 75,000 patients. Hahnemann University Hospital in Philadelphia closed within two years of acquisition by Paladin Healthcare Capital. These are the cases that have moved state legislatures and made cable news. They are not the only ones.

The other side of the ledger

A fair piece on private equity in medicine has to acknowledge the case the buyers and their academic defenders are making, because that case is what regulators are weighing in real time and what physicians considering a sale will hear in the room.

The American Investment Council reports that private equity has invested more than $280 billion across 966 American life sciences companies and 924 medical device and supplies companies over the past decade. Apologists for the model point to capital infusions that allow practices to invest in equipment, recruit difficult specialties, expand into underserved geographies, and offload the administrative and EHR overhead that has been crushing solo practitioners. Industry voices in Fierce Healthcare and analyses from McKinsey and KPMG argue that private capital is funding the telehealth, AI diagnostic, and ambulatory care innovations that legacy hospital systems have been too slow to build themselves.

There are also serious academic voices in the middle. A Wharton Executive Education essay published this May argues that the question is not whether private equity belongs in healthcare but whether the deal structures, transparency requirements, and reporting standards have caught up with the capital flows. Medical Economics coverage of new state oversight regimes notes that California’s January 2026 preclosing notification rule, alongside parallel laws now moving in Illinois, Indiana, New Mexico, and New York, is creating a more disciplined deal environment that may, on balance, be good for patients and physicians both.

The honest read is that the evidence base on PE in hospitals is consistent enough to take seriously and the evidence base on PE in physician practices is still being built. A Florida physician selling into a PE platform in 2026 is making a decision under genuine uncertainty, with strong critical literature, real defender arguments, and almost no FL-specific outcome data at the practice level.

What PitchBook and the AI capital wave add to the picture

A new line in the story arrived this quarter. PitchBook’s Q2 2026 analyst note, AI Will Deliver Care to Billions and Break the System That Built It, documents General Catalyst’s $515 million acquisition of Summa Health, an Ohio hospital system, as the first time a U.S. hospital system has been acquired by a venture capital firm. The PitchBook authors do not present Summa as an isolated event. They present it as the template for an AI-native operator model that combines hospital ownership with platform technology, and they project that more transactions of that shape are coming.

That is the new variant Florida physicians have to plan for on top of the existing PE roll-up. The independent practice that has weathered hospital acquisition, payer consolidation, and traditional PE rollups now has an additional buyer profile to recognize: the AI-native operator that is buying the practice or the system not for the patient panel alone but for the data flow that trains the next iteration of the platform. Hospital boards in Florida should expect to be asked, in writing, why they are not doing what Summa is doing. Independent practice owners should expect acquisition outreach with valuation models that look very different from the EBITDA multiples the local hospital used last year.

PitchBook is one data point in a larger conversation. The same direction is described, with different framing, by the Penn Leonard Davis Institute, the Center for American Progress, Becker’s, Health Affairs Scholar, and the Antitrust Institute. These outlets disagree about the policy response. They agree on the direction of capital flow.

Where The Atlas Accord fits

Florida physicians reading this far should have a question forming. Where is the physician voice in any of this? The answer, frankly, has not been loud enough. The major medical societies file comments and pass resolutions, and that work matters, but it is not built for the deal cadence the market is now running.

The Atlas Accord was built to be the voice. It is a physician-led alliance focused on restoring professional autonomy through collective action. Its members are physicians who have decided that the deals reshaping their working lives are not going to be negotiated competently if physicians are not in the room with shared positions, shared diligence frameworks, and shared bargaining power. The Accord’s posture is straightforward: structural problems demand structural answers, and the physician who is reading a PE term sheet alone, with their own attorney, against a buyer that has done four hundred of these, is not in a fair negotiation.

If you are evaluating a sale to a PE platform, considering a hospital partnership with a PE-backed system, or watching your specialty in Florida get rolled up around you, The Atlas Accord exists to give you a place to compare notes with peers who have already done this analysis, a shared framework for evaluating offers, and a coordinated path for taking concerns to the FMA, the Board of Medicine, and state legislators. More information is at theatlasaccord.com.

What Florida physicians should do this month

1. Map the ownership behind every practice and hospital you interact with. If you refer to a dermatology group, an ENT group, an ophthalmology platform, or an urgent care chain, find out who owns it. The same exercise applies to your own practice if you have entered into management services agreements, group purchasing arrangements, or shared services with a private equity-backed entity. Knowing who you are doing business with is not optional in 2026.
2. Read the JAMA literature on PE hospital outcomes before any conversation about a sale or partnership. The Kannan paper on hospital-acquired conditions and the follow-up ED mortality analysis are not long. Whatever you decide afterward, you will be a more informed negotiator on the other side of reading them.
3. Engage your malpractice carrier and your CPA before, not after, you receive an offer. Both have seen PE term sheets that the typical solo physician has not, and both can flag indemnity clauses, earn-out structures, and tax consequences that change the value of a deal materially.
4. Watch Tallahassee for the next Florida response to the California preclosing notification law. Other states are moving, and the FMA and physician advocacy organizations are pushing for similar transparency requirements here. The version of this law that ends up in Florida will be shaped by the physicians who show up.
5. Connect with peers who have lived through it. The Atlas Accord, your specialty society, and the FMA Council on Legislation are all places where Florida physicians who have been on either side of a PE transaction will talk candidly with colleagues who are about to be. Walking into this alone is the choice with the worst track record.

The wider point for our profession

Private equity is not going to leave healthcare. The capital is committed, the deal pipeline is full, and the regulatory response is local and uneven. What Florida physicians can change is whether the profession faces the next wave of transactions as a fragmented set of solo operators or as an organized cohort with shared positions, shared diligence, and shared bargaining power.

The reporting from PitchBook, JAMA, Health Affairs, McKinsey, Fierce Healthcare, and the Penn Leonard Davis Institute does not agree on the policy answer. The reporting does agree that the era of medicine being practiced inside structures Florida physicians built and own is ending faster than most of the profession has noticed. The Atlas Accord is one of the places organized response is being built. It is worth our time.

Frequently Asked Questions

What is private equity acquisition of physician practices, and how common is it in Florida?

Private equity acquisition of physician practices occurs when an investment firm buys a controlling stake in a practice or a group, typically rolls it into a larger platform, and looks to exit the investment in three to seven years. The Private Equity Stakeholder Project and Becker’s report that private equity firms now drive more than 90 percent of physician practice M&A activity nationally, and Florida ranks in the top three states by deal volume in dermatology, gastroenterology, ophthalmology, orthopedics, and emergency medicine.

What does the JAMA evidence actually show about patient outcomes after private equity hospital acquisitions?

The 2023 JAMA study by Kannan and colleagues analyzed 51 PE-acquired hospitals against 259 controls and found a 25.4 percent increase in hospital-acquired adverse events, a 27.3 percent increase in patient falls, a 37.7 percent increase in central line-associated bloodstream infections, and a doubling of surgical site infections after acquisition. A subsequent analysis reported a more than 13 percent increase in emergency department mortality at PE-acquired hospitals, linked to staffing and salary cuts.

What is The Atlas Accord and how does it relate to Florida physician advocacy on private equity?

The Atlas Accord is a physician-led alliance focused on restoring professional autonomy through collective action. It convenes physicians evaluating PE offers, hospital partnerships with PE-backed systems, and broader structural changes in medicine. The Accord’s role is to provide shared diligence frameworks, peer-to-peer negotiation experience, and a coordinated path for taking concerns to the FMA, the Florida Board of Medicine, and state legislators. More information is at theatlasaccord.com.

Which Florida medical practices have been acquired by private equity recently?

Visible 2025-2026 Florida transactions include Millennium Physician Group’s acquisition of eight Brevard County primary care offices serving roughly 37,000 patients under the Mosaic Health platform, Humana’s pending acquisition of MaxHealth in Sarasota from Arsenal Capital Partners’ Best Value Healthcare platform, and Elevate ENT’s continued rollup of otolaryngology practices, which now spans North Florida Center for Otolaryngology, Coastal Ear Nose & Throat, Orlando Ear Nose & Throat, Vero ENT, and South Florida ENT Associates among other Florida brands.

How does the PitchBook Q2 2026 analyst note on AI care delivery connect to the private equity story?

PitchBook’s Q2 2026 analyst note documents General Catalyst’s $515 million acquisition of Summa Health as the first time a U.S. hospital system has been acquired by a venture capital firm. PitchBook positions the transaction as the template for an AI-native operator model that combines hospital ownership with platform technology. For Florida physicians, the implication is that the existing PE roll-up of medicine is being joined by a new variant of buyer whose valuation model is built around clinical data flow rather than EBITDA alone.

A private equity firm has approached me about acquiring my Florida practice. What should I do before responding?

Read the JAMA literature on PE hospital outcomes for context. Get your malpractice carrier and your CPA into the conversation early. Talk with peers who have completed a PE transaction in your specialty, ideally through The Atlas Accord, your specialty society, or the FMA. Have an attorney experienced specifically in PE term sheets review the indemnity, earn-out, and non-compete language line by line. Then ask yourself whether the deal structure is one you would be comfortable explaining to a colleague at the FMA, the Florida Board of Medicine, and a Florida patient three years from now. If the honest answer is anything but yes, do not sign.